129 related articles for article (PubMed ID: 4004603)
1. Low-dose bromocriptine therapy in Parkinson's disease.
Pfeiffer RF; Wilken K; Glaeske C; Lorenzo AS
Arch Neurol; 1985 Jun; 42(6):586-8. PubMed ID: 4004603
[TBL] [Abstract][Full Text] [Related]
2. Bromocriptine and levodopa (with or without carbidopa) in parkinsonism.
Kartzinel R; TEYCHENNE P; Gillespie MM; Perlow M; Gielen AC; Sadowsky DA; Calne DB
Lancet; 1976 Aug; 2(7980):272-5. PubMed ID: 59850
[TBL] [Abstract][Full Text] [Related]
3. The Sydney multicentre study of Parkinson's disease. The first 18 months.
Hely MA; Morris JG; Rail D; O'Sullivan DJ; Williamson PM; Genge S; Reid WG; Broe GA
Med J Aust; 1987 Feb; 146(4):195-8. PubMed ID: 3553878
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of administration of low doses of bromocriptine and levodopa in the early treatment of Parkinson disease].
Sternić N; Kostić V
Srp Arh Celok Lek; 1992; 120(1-2):1-5. PubMed ID: 1641693
[TBL] [Abstract][Full Text] [Related]
5. Treatment of parkinson's disease with bromocriptine.
Lieberman A; Kupersmith M; Estey E; Goldstein M
N Engl J Med; 1976 Dec; 295(25):1400-4. PubMed ID: 989885
[TBL] [Abstract][Full Text] [Related]
6. A comparison of bromocriptine (Parlodel) and levodopa-carbidopa (Sinemet) for treatment of "de novo" Parkinson's disease patients.
Libman I; Gawel MJ; Riopelle RJ; Bouchard S
Can J Neurol Sci; 1987 Nov; 14(4):576-80. PubMed ID: 3319120
[TBL] [Abstract][Full Text] [Related]
7. Bromocriptine: problems with low-dose de novo therapy in Parkinson's disease.
Grimes JD; Delgado MR
Clin Neuropharmacol; 1985; 8(1):73-7. PubMed ID: 3978651
[TBL] [Abstract][Full Text] [Related]
8. The Sydney Multicentre Study of Parkinson's disease: a report on the first 3 years.
Hely MA; Morris JG; Rail D; Reid WG; O'Sullivan DJ; Williamson PM; Genge S; Broe GA
J Neurol Neurosurg Psychiatry; 1989 Mar; 52(3):324-8. PubMed ID: 2647907
[TBL] [Abstract][Full Text] [Related]
9. Bromocriptine in Parkinson disease.
Lieberman AN; Goldstein M
Pharmacol Rev; 1985 Jun; 37(2):217-27. PubMed ID: 3901046
[TBL] [Abstract][Full Text] [Related]
10. Severity of Parkinson's disease and the dosage of bromocriptine.
Larsen TA; Newman R; LeWitt P; Calne DB
Neurology; 1984 Jun; 34(6):795-7. PubMed ID: 6539444
[TBL] [Abstract][Full Text] [Related]
11. Bromocriptine: low-dose therapy in Parkinson disease.
Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
[TBL] [Abstract][Full Text] [Related]
12. Bromocriptine in Parkinson's disease: results obtained with high and low dose therapy.
Grimes JD
Can J Neurol Sci; 1984 Feb; 11(1 Suppl):225-8. PubMed ID: 6713320
[TBL] [Abstract][Full Text] [Related]
13. Adjunctive therapy with bromocriptine in Parkinson's disease.
Temlett JA; Ming A; Saling M; Fritz VU; Blumenfeld A; Bilchik TR; Becker AL; Fourie PB; Reef HE
S Afr Med J; 1990 Dec; 78(11):680-5. PubMed ID: 2251616
[TBL] [Abstract][Full Text] [Related]
14. The Sydney Multicentre Study of Parkinson's disease: a randomised, prospective five year study comparing low dose bromocriptine with low dose levodopa-carbidopa.
Hely MA; Morris JG; Reid WG; O'Sullivan DJ; Williamson PM; Rail D; Broe GA; Margrie S
J Neurol Neurosurg Psychiatry; 1994 Aug; 57(8):903-10. PubMed ID: 8057111
[TBL] [Abstract][Full Text] [Related]
15. Low-dose bromocriptine therapy in Parkinson's disease: double-blind, placebo-controlled study.
Staal-Schreinemachers AL; Wesseling H; Kamphuis DJ; vd Burg W; Lakke JP
Neurology; 1986 Feb; 36(2):291-3. PubMed ID: 3511405
[TBL] [Abstract][Full Text] [Related]
16. The effect of deprenyl and levodopa on the progression of Parkinson's disease.
Olanow CW; Hauser RA; Gauger L; Malapira T; Koller W; Hubble J; Bushenbark K; Lilienfeld D; Esterlitz J
Ann Neurol; 1995 Nov; 38(5):771-7. PubMed ID: 7486869
[TBL] [Abstract][Full Text] [Related]
17. Low-dose, slow-increase bromocriptine in patients with progressive Parkinson's disease and complications of levodopa therapy.
Stern MB; Vernon GM; Gollomp SM; Hurtig HI
Bull Clin Neurosci; 1986; 51():52-6. PubMed ID: 3455244
[TBL] [Abstract][Full Text] [Related]
18. Bromocriptine: long-term low-dose therapy in Parkinson's disease.
Teychenne PF; Bergsrud D; Elton RL; Racy A
Clin Neuropharmacol; 1986; 9(2):138-45. PubMed ID: 3708599
[TBL] [Abstract][Full Text] [Related]
19. Bromocriptine and the clinical spectrum of Parkinson's disease.
Riopelle RJ
Can J Neurol Sci; 1987 Aug; 14(3 Suppl):455-9. PubMed ID: 3676920
[TBL] [Abstract][Full Text] [Related]
20. Low dosages of bromocriptine added to levodopa in Parkinson's disease.
Hoehn MM; Elton RL
Neurology; 1985 Feb; 35(2):199-206. PubMed ID: 3969207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
